# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000886163-17-000021
Filing Date
2017-02-28
Accepted
2017-02-28 07:37:26
Documents
81
Period of Report
2016-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | lgnd-20161231x10k.htm | 10-K | 2636133
2 | EXHIBIT 23.1 | lgnd_123116xexhibit231.htm | EX-23.1 | 5023
3 | EXHIBIT 23.2 | lgnd_123116xexhibit232.htm | EX-23.2 | 2238
4 | EXHIBIT 31.1 | lgnd_123116xexhibit311.htm | EX-31.1 | 19567
5 | EXHIBIT 31.2 | lgnd_123116xexhibit312.htm | EX-31.2 | 20532
6 | EXHIBIT 32.1 | lgnd_123116xexhibit321.htm | EX-32.1 | 15749
13 |  | stockperformancegraphv3.jpg | GRAPHIC | 131829
| Complete submission text file | 0000886163-17-000021.txt |  | 11591647

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL INSTANCE DOCUMENT | lgnd-20151231.xml | EX-101.INS | 2417185
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20151231.xsd | EX-101.SCH | 68009
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20151231_cal.xml | EX-101.CAL | 140548
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20151231_def.xml | EX-101.DEF | 382610
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20151231_lab.xml | EX-101.LAB | 1067403
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20151231_pre.xml | EX-101.PRE | 592927

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33093 | Film No.: 17644718
SIC: 2834 Pharmaceutical Preparations